Jyoti Resins Q1FY27: PAT falls 32% YoY on margin squeeze despite 17% revenue growth
PAT -32.39% YoY · revenue +16.79% · margins compressing
₹87.71 Cr
+16.79% YoY
₹11.75 Cr
-32.39% YoY
12.91%
-9.3pp YoY
₹10
Jyoti Resins & Adhesives reported standalone Q1 FY27 (quarter ended June 30, 2026) revenue of Rs.87.71 Cr, up 16.8% YoY but down 5.6% QoQ off a seasonally strong Q4. Net profit fell sharply on a YoY basis to Rs.11.75 Cr, down 32.4% from Rs.17.38 Cr a year ago and down 41.5% sequentially from Rs.20.08 Cr — a clear case of the topline growing while profitability shrank, which is the story of the quarter, not the revenue print. No exceptional items appear in the current or comparable periods, so this is a clean, unadjusted decline rather than a one-off distortion.
Q1 FY-2027 vs prior quarters
The compression sits squarely on the cost-of-materials line: cost of materials consumed jumped to Rs.52.21 Cr, 59.5% of revenue, versus Rs.23.75 Cr (31.6% of revenue) a year ago and Rs.30.88 Cr (33.2% of revenue) last quarter. Operating margin (PBT plus finance cost and depreciation, less other income, over revenue from operations) fell to 14.42% from 27.48% YoY and 26.87% QoQ; net margin on total income fell to 12.91% from 22.24% YoY and 21.04% QoQ. This matches management's own Q4 FY26 concall warning of 'significant near-term margin pressure in Q1 due to a sharp rise in raw material costs' — the guidance was directionally met, though the severity (margins roughly halving YoY) is steep even against that warning, and the current 12.91% NPM sits below the 18-22% steady-state net-margin range the company has separately guided toward for FY27 as it works to pass on 60-70% of the raw-material cost increase via price hikes effective May 2026. No formal Street consensus for this micro-cap's Q1 FY27 print was found in a web search; the only external reference located was a standing 'buy' call with a Rs.1,764 target based on 22x FY27e earnings, which is a full-year thesis, not a quarterly estimate, so vsStreet is left unknown rather than inferred. Management's own press commentary on this specific result was not available in the filing to quote directly. EPS (basic) came in at Rs.10 for the quarter versus Rs.14 YoY and Rs.17 QoQ, tracking the profit decline.
The stock went into the print at ₹840, down 12.9% over the past month of trading.
Management guides for 15-20% annual volume growth, targeting over INR 500 crore revenue in the next two to three years. They anticipate significant near-term margin pressure in Q1 due to a sharp rise in raw material costs, but aim to sustain long-term EBITDA margins of 23-25%. Strategic focus includes aggressive geogra
— This quarter: met
The quarter's other corporate context — the Board approving these results and taking the limited review report (unqualified, from R Kabra & Co LLP) on record on August 11, 2026, and the company's June 27, 2026 announcement of plans for a direct NSE listing — are procedural/strategic items that don't bear directly on this quarter's operating numbers. Sets up FY27 as a margin-recovery story: whether the raw-material pass-through restores OPM toward the long-term-guided 23-25% EBITDA margin band, and whether the previously flagged elevated receivables normalize within the two quarters management targeted, are now the two things to track against a still-healthy 16.8% YoY revenue growth trend.
W1
Whether the 60-70% raw-material cost pass-through (price hikes effective May 2026) restores operating margin toward the long-term-guided 23-25% EBITDA band over the next 1-2 quarters.
W2
Receivables normalization — management targeted bringing elevated receivables back to normal within two quarters of the Q4 FY26 call, i.e. by Q3 FY27.
W3
Revenue growth sustaining near the guided 15-20% annual volume growth pace (16.8% YoY this quarter) toward the stated >Rs.500 Cr revenue target in 2-3 years.
Figures converted from Rs. Lakhs to Rs. Crore. Filing is standalone-only (no consolidated statement present). No exceptional items in current or any comparable period. Total Income (91.02) is Rs.1 Lakh below Revenue+Other Income (91.03) due to source rounding; PBT-tax ties exactly to PAT.
Raw Materials Crushed the Margin, But Volume Resilience Holds the Case
Revenue jumped 17%, but net profit fell 32%—the widest gap ever. The raw material spike explains most of it, yet margin recovery is heavily hedged, and receivables spiked to ₹150 Cr. The long-term story is intact; the near-term one is strained.
₹87.7 Cr
+16.8% YoY
14.4%
vs 23-25% target
₹11.8 Cr
-32.3% YoY
10%
despite 7% price hike
On paper, Jyoti Resins reports revenue up 17% to ₹87.7 Cr. Then you see net profit crashed 32% to ₹11.8 Cr. That gap—a 900-basis-point margin collapse—is the entire quarter. Raw materials are the culprit, but the recovery is heavily hedged, and the working capital story is darkening.
Where the margin went
EBITDA landed at 14.4%, down from the company's 23-25% long-term target. Management pins 6-7 percentage points on raw material costs—vinyl acetate monomer (VAM) spiked from ₹75–78/kg to ₹170/kg in March and April before settling at ₹100/kg. But that accounts for only 7 points of the 9-point miss. The remainder came from discretionary spending: dealer engagement doubled (₹2 Cr to ₹4.5 Cr for 54 dealer meets across new territories), and employee costs climbed 25% quarter-on-quarter (hiring 42 new sales staff as the network grew from 520 to 562 people). Management framed both as growth investments, not margin degradation. Fair enough—but it means the 14.4% is not a pure raw-material story.
Net profit margin suffered even more—down to 12.9% from a prior baseline of ~18-19%. That 550–700 basis-point drop outpaces the EBITDA erosion, suggesting hidden headwinds beyond raw materials. Working capital drag is the likely culprit: receivables spiked to ₹150 Cr (roughly 52 days of annualized revenue) from an estimated ₹75–80 Cr baseline. That's a cash conversion hit that doesn't show in EBITDA but crushes net profit. Management attributed it to geographic expansion (new markets in Jharkhand, North India, UP) and promised normalization to 120 days within 1–2 quarters. Yet 2 quarters from now is still Q3, and the ₹75 Cr working capital overshoot is today's problem.
Management's claims—and what holds up
Volume growth 10% despite aggressive 7% mid-quarter price hike proves brand strength
Capacity expansion (3,500-tonne/month, 80% complete, live Q2) can generate ₹600–650 Cr revenue
EBITDA margin will recover to 23-25% in Q2 after raw material stabilization
Receivables will normalize to 120 days within 1–2 quarters
PAT decline of 32% reflects one-time raw material absorption
Verdict by claim: The first two are supported. Volume resilience is real—10% unit growth survived a 7% price hike mid-quarter, proving customer acceptance and brand loyalty. The carpenter network (210,000 registered, up 10,000 in Q1) and dealer expansion into new territories (Jharkhand, North India) show execution traction. Capacity backing is also sound: 3,500-tonne/month production is 80% built and ready for Q2, backed by a zero-debt balance sheet holding ₹160 Cr cash.
The margin recovery claim, however, is heavily hedged. When pressed on Q2 margins, the MD said: 'it is too early to say we can maintain 28–29% EBITDA in Q2; the situation was exceptional.' That's not a recovery promise—it's a dodge. Management reaffirmed the long-term 23–25% EBITDA target but conspicuously avoided specific FY27 full-year guidance. That's unusual for a guidance reaffirmation and signals lower confidence in the near-term bounce.
The receivables and PAT claims are partial. Receivables ₹150 Cr is real and material, but management's vague promise of normalization 'within 1–2 quarters' masks the fact that no concrete steps (extended settlement terms, channel financing, credit tightening) were announced. And the PAT miss is not fully explained: 6–7% raw material impact + 3–4% discretionary spending doesn't fully account for a 32% profit decline. Finance costs, tax inefficiency, or working capital drag—none was explicitly quantified.
What changed on this call
Raw material procurement
Now locked into 90-day fixed contracts with suppliers for Q2 (vs. 30-day spot buying before). Hedge against March–April VAM spike (₹75→₹170/kg).
Upgrade: Proactive cost management, reduces future crisis risk
Brand investment
Dealer meets doubled: ₹2 Cr to ₹4.5 Cr; 30 to 54 events in Q1; onboarded brand ambassador Pankaj Tripathi; targeting 6–7% of sales for brand spend (up from prior standard).
Upgrade: Building moat as company scales; market expansion credibility
OEM segment prioritization
Now 6% of revenue (vs. near-zero before), targeting 10–12% by FY28–29. Focus on modular kitchens and high-end furniture in Bangalore, Telangana, Delhi.
Upgrade: New revenue vector, higher margins, reduces carpenter-channel dependency
Margin recovery timeline
Prior call promised 'normalize in Q1 / Q2 after raw materials ease.' This call: hedged to 'too early to say,' acknowledged 'exceptional' situation affects all 4 quarters.
Downgrade: Lowered near-term recovery confidence
How the street is positioned
The stock is trading at ₹836.05, down 35% from its all-time high of ₹1,289.95 and trading below its 20-day, 50-day, and 200-day moving averages (₹922.69, ₹950.87, ₹984.18 respectively). The RSI is 17.9—deeply oversold—suggesting capitulation selling or institutional head-shaking. Volume is increasing, a sign of either forced selling or scavengers testing support.
Institutional interest has evaporated. FII holdings fell to 0.06% (down 0.03pp quarter-on-quarter), and DII holdings collapsed to 0.08% (down 0.35pp). Promoters hold steady at 54.37%, so there's no insider selling signal. The market's day-1 reaction to the result was a limp -0.2%, suggesting the disappointment was priced in—or the market doesn't yet appreciate the depth of the near-term strain.
The 35% drawdown from the all-time high and oversold RSI might seem like value. But the fundamental deterioration—₹75 Cr of working capital overshoot, net profit down 32% YoY, margin recovery heavily hedged—argues that the stock is not yet punished enough for the execution risk. A bounce is possible if Q2 EBITDA ticks back to 18%+ or receivables show concrete normalization; absent that, the downside remains open.
The debate
Risks, ranked by how much they should concern a holder
Raw material price stabilization uncertain
HighVAM currently ₹100/kg vs. ₹75–78/kg baseline. If geopolitical tension (West Asia unrest driving crude/freight) persists, VAM stays >₹100/kg. At that level, 23–25% EBITDA margin target is unrealistic. The long-term case crumbles.
Working capital deterioration (receivables anchor)
High₹150 Cr receivables (vs. ₹75–80 Cr baseline) represents ₹75 Cr of cash trapped in the cycle. If normalization drags beyond Q3, cash conversion remains impaired. Capex funding and growth financing become dependent on external credit or asset sales.
PAT margin squeeze disproportionate to EBITDA miss
HighPAT down 32% YoY despite 17% revenue growth; EBITDA down only 900bp (23% vs. 14.4%). Suggests finance costs, tax inefficiency, or working capital drag beyond raw materials. Unexplained 550–700bp net-margin erosion is opaque and concerning.
Capacity utilization risk (fixed cost leverage)
Medium3,500-tonne brownfield expansion needs 65–70% utilization to hit ₹600–650 Cr revenue and 22–25% EBITDA. If volume growth slows, demand softens, or price deflates to clear inventory, fixed costs press EBITDA lower. Leverage becomes negative instead of positive.
Geographic expansion ROI unproven
Medium10 emerging states (Jharkhand, North India, UP, West Bengal, Telangana) are early-stage. If penetration lags brand expectations or competitive response intensifies, receivables stay elevated longer. 3–5 year payback cycles in new markets are standard; execution risk is real.
Competitive intensity and price deflation
MediumWood adhesive market has established players (Jivanjor, Bondtite) with longer history. As Euro expands into new territories, rivals will price-cut to defend share. Volume growth may prove unsustainable at current margin assumptions.
What to watch next
1 · Q2 EBITDA margin recovery (the pivot point)
If raw materials have stabilized and discretionary spend normalizes, Q2 EBITDA should tick toward 18–20%. Below 16% and the long-term 23–25% target becomes unrealistic. Above 20% and the recovery narrative holds. This is the first acid test.
2 · Receivables normalization (concrete progress, not just promises)
Concrete evidence of working capital improvement: receivables moving from ₹150 Cr toward ₹120 Cr baseline by Q3, or explicit extended settlement arrangements with dealers, or channel financing deals announced. Vague promises of 'within 2 quarters' are noise; actions matter.
3 · Brownfield capacity commissioning and ramp (Q2 FY27 onwards)
3,500-tonne/month plant goes live in Q2. Watch for: (a) actual production volumes (targeting 2,000+ tonne/month by Q3), (b) utilization rate (needs 65–70% to hit ₹600–650 Cr target), (c) margins from the new capacity (should be in line with 22–25% guidance or higher due to economies of scale).
4 · Full-year FY27 guidance (will management commit?)
On this call, management avoided specific FY27 EBITDA guidance (red flag). By Q2, they must either commit to a FY27 range (e.g., 18–20% EBITDA) or explain why not. Silence is a bearish signal.
The single number to track
Q2 EBITDA margin. If it reaches 18%+, the recovery narrative holds and shares deserve re-rating. Below 16%, and the near-term is broken; the long-term case survives, but the timeline to profitability normalcy extends. The 14.4% Q1 print is a floor; upside requires execution on raw material hedges and cost discipline.
Jyoti Resins' long-term transformation (₹500 Cr revenue, 23–25% EBITDA, 3,500-tonne capacity) is real and funded. Volume resilience (10% growth despite adversity) and geographic penetration are proving out. But the near-term is strained: margin recovery is heavily hedged, receivables are a ₹75 Cr overshoot, and net profit leverage is broken. The 35% drawdown from the all-time high looks cheap on a three-year view; it's probably fair on a six-quarter view. Hold existing positions pending Q2 results; new longs should wait for concrete evidence of margin and working capital recovery.
Raw material shock crushed margins; volume strength proven but recovery heavily hedged
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit prior volume guidance (15-20% → 10% achieved despite adversity). Reaffirmed ₹500 Cr FY29, 23-25% EBITDA targets. But: Avoided specific FY27 margin guidance; Q1 EBITDA miss unexpectedly large (6-7% raw material hit + 3-4% discretionary capex). PAT miss (32% YoY) not fully explained.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered strong 17% revenue growth (10% volume + 7% price) and 210k carpenter network expansion, proving brand strength and execution. But 14.4% EBITDA vs 23-25% guidance is a 900bp miss, driven by raw material shock (VAM ₹75→₹170/kg). Margin recovery to 23-25% is heavily hedged ('too early to say Q2'); management avoided committing to FY27 full-year guidance. Near-term risk: ₹150 Cr receivables and PAT down 32% YoY suggest working capital strain. Long-term case intact (₹500 Cr FY29 target, capacity expanding to 3,500 tonne/month), but near-term execution unproven.
₹87.7 Cr
Revenue · +16.8% YoY₹11.8 Cr
Reported PAT · −32.3% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Volume growth 10% despite aggressive price increases mid-quarter
METRevenue 17% YoY (7% price, 10% volume per mgmt), confirms brand strength
Q1 EBITDA 14.4% will normalize to 23-25% in Q2 after raw material price stabilization
OVERSTATEDMD explicitly hedged: 'it is too early to say we can maintain 28-29% EBITDA in Q2'; called situation 'exceptional'
Capacity expansion can generate ₹600-650 Cr annual revenue from brownfield
MET3,500 tonne/month capacity target, 80% complete, ready Q2; extrapolation from 1,300 tonne/month baseline plausible but unproven
Receivables elevated due to new market expansion; will normalize to 120 days in 1-2 quarters
PartialReceivables ₹150 Cr vs estimated ₹75-80 Cr baseline; new states explained (Jharkhand, North India) but no concrete timeline given ('within 1-2 quarters' is vague)
PAT decline of 32% YoY despite 17% revenue growth reflects one-time raw material cost absorption
PartialOPM 14.4% (raw material impact 6-7%), EBITDA impact fully acknowledged. But PAT margin compressed more than EBITDA margin, suggesting additional drag (working capital, increased employee costs noted). Not fully explained.
Earnings quality
What changed since the last call
Raw material procurement strategy tightened
UpgradeNow locked 90-day contracts with suppliers for Q2 (vs 30-day spot in Q1); pro-active hedge against March-April VAM spike (₹75→₹170/kg). Reduces future crisis risk.
Brand investment ramped to 6-7% of sales target
UpgradeDoubled dealer meets (30→54, ₹2 Cr→₹4.5 Cr), onboarded brand ambassador (Pankaj Tripathi). Aiming to build moat as company scales to ₹500 Cr.
OEM segment prioritization accelerated
UpgradeNow 6% of revenue, targeting 10-12% by FY28-29. Modular kitchens/furniture market focus (Bangalore, Telangana, Delhi). New revenue vector vs prior furniture/construction-only.
Margin recovery timeline extended
DowngradePrior call (FY26) promised 'significant margin pressure in Q1' + recovery. This call: Hedged heavily on Q2 recovery ('too early to say 28-29%'), acknowledged 'exceptional' raw material shock impacts all 4 quarters.
The Q&A
Analysts pressed hard on (1) why Q1 EBITDA 14.4% when raw materials only 6-7% impact (MD: discretionary dealer meets ₹4.5 Cr + aggressive sales promotion), (2) whether ₹500 Cr FY29 target is achievable at 5-7% CAGR vs claimed 15-20% volume (MD: hedged on price realization normalization), (3) receivables spike from ₹75 Cr to ₹150 Cr (MD: new market expansion cost, will normalize in 2 quarters). Analysts unconvinced on margin recovery timing; moderate skepticism but no outright dismissal of long-term thesis.
Capacity expansion revenue potential — Ritika Sheth, analyst
Answered₹600-650 Cr revenue from brownfield at 3,500-tonne capacity; 22-25% EBITDA as long-term aspiration; raw material contracts now 90-day locked.
Employee cost inflation — Smith Gala, analyst
AnsweredHired 42 new sales force (520→562), onboarded new talents for business ops. Will normalize to 11-13% of revenue (industry standard). Appraisals contributed to spike.
Volume vs price split guidance — Smith Gala, analyst
PartialAlways believe more volume growth needed. Q1: 7% price from mid-May increase; 70% of growth from revenue (price+volume combined). Still aiming 15-20% volume long-term; price is market-dependent.
Margin recovery timing Q2 — Smith Gala, analyst
DodgedToo early to say. It's a cooling period but not back to original levels. Effort mainly on growth, not margin recovery.
Trade receivables nature and risk — Saurabh Rathore, analyst
AnsweredDebtors spread across 13,000 retailers, bad debt <0.5% for 20 years. New market expansion drives higher days. Will normalize to 120-130 days within 2 quarters, aided by channel financing.
Dealer meets ROI unclear — Saket Saraogi, analyst
PartialFY23-24 was consolidation year. Last 4 quarters: 15-20% growth (Q4 +20%, Q2 +16%). In transformation phase (tech, HR, SOPs, capacity). Future-ready investments now bearing fruit.
Export and international expansion — Dishant Shah, analyst
AnsweredToo early. Focus on domestic ₹8,000 Cr market to reach ₹1,000 Cr (20% share). After 3 years of stabilization, may consider exports. Asset-light brownfield investment should capitalize first.
Working capital and debtor cycle improvement — Arjun, analyst
AnsweredAiming 120 days. All states (Gujarat, Rajasthan, MP, Maharashtra) took 2-3 years to normalize after entry. UP taking same path; need to build network first, cannot rush collections without risking retailer relationships.
Guidance
₹600-650 Cr annual from 3,500-tonne brownfield capacity (Q2 FY27 onwards)
Medium80% capex complete, ready Q2 FY27. Based on extrapolation from 1,300 tonne/month baseline (current avg.) to 65-70% utilization of 3,500 tonne/month. Seasonal Q3/Q4 stronger (March peak 2,400 tonne/month historically).
₹500 Cr top-line by FY29 (end of 3 years from FY27)
MediumImplies 15-20% CAGR if price realization normalizes to ₹75-80 levels (vs current ₹100+ after May hike). Achievable only if volume growth maintains 15-20% trajectory and receivables normalize.
22-25% EBITDA margin long-term (multi-year aspiration, NOT FY27 specific)
LowQ1 delivered 14.4% (900bp miss). MD explicitly hedged: 'it will affect all 4 quarters' but 'will try to maintain 22-25% longer-term.' No FY27 full-year margin guidance offered. Raw material stabilization expected Q2 but 'too early to say' if margins revert to 28-29%.
₹45-50 Cr for Greenfield (future 1,500 tonne/month capacity), phased over years
High50% land, 50% construction/machinery. Only after brownfield capacity at 100% utilization. Funded via internal accruals (zero-debt model). Timeline post-FY27.
Risks the call surfaced
Raw material cost inflation
HighVAM spiked ₹75/kg→₹170/kg (March) driven by geopolitical crisis (West Asia unrest, crude price spike, freight rates). Now at ₹100/kg. If geopolitical remains unstable, VAM could stay >₹100/kg, eroding 23-25% margin assumption.
Working capital deterioration
HighTrade receivables jumped to ₹150 Cr from ₹75-80 Cr baseline; represents 52 days of revenue vs management's stated target of 120 days. If receivables stay elevated, cash conversion weakens and growth financing becomes dependent on external credit.
PAT margin compression
HighPAT down 32% YoY despite 17% revenue growth (NPM 12.9% vs ~18-19% baseline). Disproportionate decline vs EBITDA suggests finance cost, tax inefficiency, or unacknowledged cost inflation beyond raw materials.
Geographic expansion execution risk
MediumCompany in 10 emerging states (Jharkhand, North India, UP, West Bengal, Telangana) targeting 15-20% volume growth. If penetration lags (brand unknown, competitive response, retailer adoption slow), revenue targets miss and receivables stay elevated.
Capacity utilization uncertainty
MediumBrownfield expands capacity from 2,000 to 3,500 tonne/month; management targets 65-70% utilization to hit ₹600-650 Cr revenue. If demand growth lags (macro slowdown, volume guidance miss, price deflation), utilization falls and EBITDA leverage becomes negative (fixed costs pressed).
Management
Score 7/10. Detailed, granular on volumes, segments, capex, dealer network. But heavily hedged on near-term margin recovery ('too early to say Q2 margins will be 28-29%'); avoided committing to specific FY27 full-year EBITDA guidance (unusual for guidance reaffirmation). Mixed. Hit 10% volume growth (within 15-20% guidance) despite adversity; geographic expansion (210k carpenter network, 65 territories) on track. But missed EBITDA by 900bp (14.4% vs 23-25%), and PAT down 32% YoY (not fully explained). Track record: FY23-24 consolidation year (flat growth), recent 4 quarters showing 15-20% growth (recovering).
1 · Q2 FY27 (Aug-Sep 2026)
3,500-tonne/month capacity operationalization; raw material stabilization; margin recovery evidence
2 · H2 FY27 (Oct 2026-Mar 2027)
Geographic expansion (Jharkhand, North India cities live); OEM segment ramp to 10-12% of revenue
3 · Q3/Q4 FY27
Receivables normalization to 120-130 days; working capital cycle improvement
Long-term case intact (₹500 Cr FY29 target, capacity expanding to 3,500 tonne/month), but near-term execution unproven.